基本信息
浏览量:136
职业迁徙
个人简介
After working at the American National Institutes of Health (NIH), National Institute of Health Sciences (NIHS), and Fujisawa Pharmaceutical Co. (now Astellas Pharma Inc.), Dr. Kato become a professor at the Keio University School of Medicine. There he engaged in research into variations in drug-metabolizing enzymes (CYP) across different genders, species, ages, and states of illness. In particular, he put emphasis on the importance of pharmacokinetic research in drug development and made contributions to furthering progress in this area.
On the international stage, Dr. Kato also served as editor of Xenobiotica, followed immediately by founding editor of Pharmacogenetics. Moreover, he was the third chairperson of the International Society for the Study of Xenobiotics (1987-1988), and the chairperson of the second ISSX conference (1988 in Kobe, Japan).
On the international stage, Dr. Kato also served as editor of Xenobiotica, followed immediately by founding editor of Pharmacogenetics. Moreover, he was the third chairperson of the International Society for the Study of Xenobiotics (1987-1988), and the chairperson of the second ISSX conference (1988 in Kobe, Japan).
研究兴趣
论文共 264 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Yo Kawabata, Masaya Kimura,Yutaka Wada,Ryo Nagase,Ryuichi Kato, Nobuji Kato,Keiichi Hori,Takafumi Matsui
AIAA Propulsion and Energy 2020 Forum (2020)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn